nodes	percent_of_prediction	percent_of_DWPC	metapath
Ursodeoxycholic acid—ABCB11—Doxorubicin—bone cancer	0.126	0.192	CbGbCtD
Ursodeoxycholic acid—ABCC2—Carboplatin—bone cancer	0.116	0.176	CbGbCtD
Ursodeoxycholic acid—ABCC4—Methotrexate—bone cancer	0.108	0.164	CbGbCtD
Ursodeoxycholic acid—ABCC2—Cisplatin—bone cancer	0.0992	0.151	CbGbCtD
Ursodeoxycholic acid—SLCO1A2—Methotrexate—bone cancer	0.0777	0.118	CbGbCtD
Ursodeoxycholic acid—ABCC2—Doxorubicin—bone cancer	0.0665	0.101	CbGbCtD
Ursodeoxycholic acid—ABCC2—Methotrexate—bone cancer	0.0644	0.0978	CbGbCtD
Ursodeoxycholic acid—AKR1C2—Benzo(a)pyrene metabolism—CYP3A4—bone cancer	0.0116	0.083	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A1—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.00685	0.0491	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.00621	0.0445	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Felbamate Metabolism—CYP3A4—bone cancer	0.00621	0.0444	CbGpPWpGaD
Ursodeoxycholic acid—AKR1C2—Metapathway biotransformation—CYP4V2—bone cancer	0.00546	0.0391	CbGpPWpGaD
Ursodeoxycholic acid—ABCB11—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.00404	0.0289	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A1—Drug Induction of Bile Acid Pathway—CYP3A4—bone cancer	0.004	0.0287	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A1—Farnesoid X Receptor  Pathway—CYP3A4—bone cancer	0.00366	0.0262	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.00364	0.0261	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Drug Induction of Bile Acid Pathway—CYP3A4—bone cancer	0.00363	0.026	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.00357	0.0256	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Farnesoid X Receptor  Pathway—CYP3A4—bone cancer	0.00332	0.0238	CbGpPWpGaD
Ursodeoxycholic acid—ABCC2—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.00328	0.0235	CbGpPWpGaD
Ursodeoxycholic acid—ABCC2—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.00307	0.022	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A2—Orphan transporters—TUBB4B—bone cancer	0.00306	0.0219	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A2—Orphan transporters—TUBB2A—bone cancer	0.00264	0.0189	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Nuclear Receptor transcription pathway—NR1I2—bone cancer	0.00258	0.0185	CbGpPWpGaD
Ursodeoxycholic acid—Chenodeoxycholic acid—CYP3A4—bone cancer	0.00248	1	CrCbGaD
Ursodeoxycholic acid—ABCB11—Drug Induction of Bile Acid Pathway—CYP3A4—bone cancer	0.00236	0.0169	CbGpPWpGaD
Ursodeoxycholic acid—ABCB11—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.00232	0.0166	CbGpPWpGaD
Ursodeoxycholic acid—ABCB11—Farnesoid X Receptor  Pathway—CYP3A4—bone cancer	0.00216	0.0155	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—Drug Induction of Bile Acid Pathway—CYP3A4—bone cancer	0.00213	0.0152	CbGpPWpGaD
Ursodeoxycholic acid—ABCC2—Irinotecan Pathway—CYP3A4—bone cancer	0.0021	0.015	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.00209	0.0149	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00204	0.0146	CbGpPWpGaD
Ursodeoxycholic acid—ABCC2—Drug Induction of Bile Acid Pathway—CYP3A4—bone cancer	0.00179	0.0128	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Orphan transporters—TUBB4B—bone cancer	0.00179	0.0128	CbGpPWpGaD
Ursodeoxycholic acid—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.00176	0.0126	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Orphan transporters—TUBB2A—bone cancer	0.00155	0.0111	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—Ectoderm Differentiation—BCOR—bone cancer	0.00153	0.0109	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—Fluoropyrimidine Activity—DHFR—bone cancer	0.00148	0.0106	CbGpPWpGaD
Ursodeoxycholic acid—ABCB11—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.00136	0.00971	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.00132	0.00948	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Generic Transcription Pathway—ZNF77—bone cancer	0.00132	0.00943	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.00118	0.00842	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.0011	0.00789	CbGpPWpGaD
Ursodeoxycholic acid—ABCC2—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.00108	0.00774	CbGpPWpGaD
Ursodeoxycholic acid—AKR1C2—Metapathway biotransformation—CYP3A4—bone cancer	0.00108	0.00773	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.00107	0.00768	CbGpPWpGaD
Ursodeoxycholic acid—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.00103	0.00738	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Xenobiotics—CYP3A4—bone cancer	0.000983	0.00704	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Tamoxifen metabolism—CYP3A4—bone cancer	0.000946	0.00677	CbGpPWpGaD
Ursodeoxycholic acid—AKR1C2—Metapathway biotransformation—GSTP1—bone cancer	0.000923	0.00661	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Metapathway biotransformation—CYP4V2—bone cancer	0.000877	0.00628	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A2—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000748	0.00536	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—Platelet degranulation—SPARC—bone cancer	0.000743	0.00532	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—Response to elevated platelet cytosolic Ca2+—SPARC—bone cancer	0.000708	0.00507	CbGpPWpGaD
Ursodeoxycholic acid—AKR1C2—Metabolism—NDUFA12—bone cancer	0.000656	0.0047	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A2—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000646	0.00462	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000643	0.00461	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Gene Expression—ZNF77—bone cancer	0.000634	0.00454	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A2—Metabolism—NDUFA12—bone cancer	0.000585	0.00419	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Biological oxidations—CYP3A4—bone cancer	0.00057	0.00408	CbGpPWpGaD
Ursodeoxycholic acid—AKR1C2—Metabolism—NT5C3A—bone cancer	0.000544	0.00389	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Tryptophan metabolism—CYP3A4—bone cancer	0.000505	0.00362	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Biological oxidations—GSTP1—bone cancer	0.000487	0.00349	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A2—Metabolism—NT5C3A—bone cancer	0.000485	0.00347	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Generic Transcription Pathway—NR1I2—bone cancer	0.000446	0.00319	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000437	0.00313	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000408	0.00292	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000403	0.00289	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000377	0.0027	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A1—Metabolism—NDUFA12—bone cancer	0.000377	0.0027	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Metabolism—NDUFA12—bone cancer	0.000342	0.00245	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000331	0.00237	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—Fluoropyrimidine Activity—TP53—bone cancer	0.00033	0.00236	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—Platelet activation, signaling and aggregation—SPARC—bone cancer	0.00033	0.00236	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—NRF2 pathway—GSTP1—bone cancer	0.000326	0.00233	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—NRF2 pathway—TGFBR2—bone cancer	0.000326	0.00233	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A1—Metabolism—NT5C3A—bone cancer	0.000312	0.00224	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Gene Expression—FUS—bone cancer	0.00031	0.00222	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—Platelet activation, signaling and aggregation—GNA11—bone cancer	0.000301	0.00216	CbGpPWpGaD
Ursodeoxycholic acid—Jaundice—Epirubicin—bone cancer	0.000285	0.00143	CcSEcCtD
Ursodeoxycholic acid—Urinary tract infection—Epirubicin—bone cancer	0.000284	0.00143	CcSEcCtD
Ursodeoxycholic acid—Conjunctivitis—Epirubicin—bone cancer	0.000284	0.00143	CcSEcCtD
Ursodeoxycholic acid—Dysuria—Doxorubicin—bone cancer	0.000284	0.00143	CcSEcCtD
Ursodeoxycholic acid—NR1H4—Metabolism—NT5C3A—bone cancer	0.000283	0.00203	CbGpPWpGaD
Ursodeoxycholic acid—Upper respiratory tract infection—Doxorubicin—bone cancer	0.000282	0.00142	CcSEcCtD
Ursodeoxycholic acid—Haemoglobin—Methotrexate—bone cancer	0.000282	0.00142	CcSEcCtD
Ursodeoxycholic acid—Haemorrhage—Methotrexate—bone cancer	0.000281	0.00141	CcSEcCtD
Ursodeoxycholic acid—Sweating—Epirubicin—bone cancer	0.00028	0.00141	CcSEcCtD
Ursodeoxycholic acid—Pollakiuria—Doxorubicin—bone cancer	0.00028	0.00141	CcSEcCtD
Ursodeoxycholic acid—Haematuria—Epirubicin—bone cancer	0.000279	0.0014	CcSEcCtD
Ursodeoxycholic acid—Pharyngitis—Methotrexate—bone cancer	0.000278	0.0014	CcSEcCtD
Ursodeoxycholic acid—Urinary tract disorder—Methotrexate—bone cancer	0.000277	0.00139	CcSEcCtD
Ursodeoxycholic acid—Photosensitivity reaction—Doxorubicin—bone cancer	0.000277	0.00139	CcSEcCtD
Ursodeoxycholic acid—Hepatobiliary disease—Epirubicin—bone cancer	0.000277	0.00139	CcSEcCtD
Ursodeoxycholic acid—Weight increased—Doxorubicin—bone cancer	0.000276	0.00139	CcSEcCtD
Ursodeoxycholic acid—Epistaxis—Epirubicin—bone cancer	0.000276	0.00139	CcSEcCtD
Ursodeoxycholic acid—Urethral disorder—Methotrexate—bone cancer	0.000275	0.00138	CcSEcCtD
Ursodeoxycholic acid—ABCC2—NRF2 pathway—TGFBR2—bone cancer	0.000275	0.00197	CbGpPWpGaD
Ursodeoxycholic acid—ABCC2—NRF2 pathway—GSTP1—bone cancer	0.000275	0.00197	CbGpPWpGaD
Ursodeoxycholic acid—Weight decreased—Doxorubicin—bone cancer	0.000275	0.00138	CcSEcCtD
Ursodeoxycholic acid—Sinusitis—Epirubicin—bone cancer	0.000274	0.00138	CcSEcCtD
Ursodeoxycholic acid—ABCC4—Platelet activation, signaling and aggregation—IL3—bone cancer	0.000273	0.00196	CbGpPWpGaD
Ursodeoxycholic acid—Pneumonia—Doxorubicin—bone cancer	0.000272	0.00137	CcSEcCtD
Ursodeoxycholic acid—Infestation—Doxorubicin—bone cancer	0.000271	0.00136	CcSEcCtD
Ursodeoxycholic acid—Infestation NOS—Doxorubicin—bone cancer	0.000271	0.00136	CcSEcCtD
Ursodeoxycholic acid—Visual impairment—Methotrexate—bone cancer	0.00027	0.00136	CcSEcCtD
Ursodeoxycholic acid—Hypersensitivity—Cisplatin—bone cancer	0.000268	0.00134	CcSEcCtD
Ursodeoxycholic acid—Renal failure—Doxorubicin—bone cancer	0.000266	0.00134	CcSEcCtD
Ursodeoxycholic acid—Haemoglobin—Epirubicin—bone cancer	0.000264	0.00133	CcSEcCtD
Ursodeoxycholic acid—Jaundice—Doxorubicin—bone cancer	0.000264	0.00132	CcSEcCtD
Ursodeoxycholic acid—Rhinitis—Epirubicin—bone cancer	0.000263	0.00132	CcSEcCtD
Ursodeoxycholic acid—Urinary tract infection—Doxorubicin—bone cancer	0.000263	0.00132	CcSEcCtD
Ursodeoxycholic acid—Conjunctivitis—Doxorubicin—bone cancer	0.000263	0.00132	CcSEcCtD
Ursodeoxycholic acid—Haemorrhage—Epirubicin—bone cancer	0.000263	0.00132	CcSEcCtD
Ursodeoxycholic acid—Eye disorder—Methotrexate—bone cancer	0.000262	0.00132	CcSEcCtD
Ursodeoxycholic acid—Tinnitus—Methotrexate—bone cancer	0.000262	0.00131	CcSEcCtD
Ursodeoxycholic acid—Asthenia—Cisplatin—bone cancer	0.000261	0.00131	CcSEcCtD
Ursodeoxycholic acid—Pharyngitis—Epirubicin—bone cancer	0.000261	0.00131	CcSEcCtD
Ursodeoxycholic acid—Cardiac disorder—Methotrexate—bone cancer	0.00026	0.00131	CcSEcCtD
Ursodeoxycholic acid—Sweating—Doxorubicin—bone cancer	0.000259	0.0013	CcSEcCtD
Ursodeoxycholic acid—Urinary tract disorder—Epirubicin—bone cancer	0.000259	0.0013	CcSEcCtD
Ursodeoxycholic acid—Oedema peripheral—Epirubicin—bone cancer	0.000259	0.0013	CcSEcCtD
Ursodeoxycholic acid—Haematuria—Doxorubicin—bone cancer	0.000258	0.0013	CcSEcCtD
Ursodeoxycholic acid—Connective tissue disorder—Epirubicin—bone cancer	0.000258	0.0013	CcSEcCtD
Ursodeoxycholic acid—Urethral disorder—Epirubicin—bone cancer	0.000257	0.00129	CcSEcCtD
Ursodeoxycholic acid—ABCC4—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000256	0.00183	CbGpPWpGaD
Ursodeoxycholic acid—Hepatobiliary disease—Doxorubicin—bone cancer	0.000256	0.00129	CcSEcCtD
Ursodeoxycholic acid—Epistaxis—Doxorubicin—bone cancer	0.000255	0.00128	CcSEcCtD
Ursodeoxycholic acid—Angiopathy—Methotrexate—bone cancer	0.000255	0.00128	CcSEcCtD
Ursodeoxycholic acid—Sinusitis—Doxorubicin—bone cancer	0.000254	0.00128	CcSEcCtD
Ursodeoxycholic acid—Immune system disorder—Methotrexate—bone cancer	0.000253	0.00127	CcSEcCtD
Ursodeoxycholic acid—Visual impairment—Epirubicin—bone cancer	0.000253	0.00127	CcSEcCtD
Ursodeoxycholic acid—Mediastinal disorder—Methotrexate—bone cancer	0.000253	0.00127	CcSEcCtD
Ursodeoxycholic acid—Chills—Methotrexate—bone cancer	0.000252	0.00126	CcSEcCtD
Ursodeoxycholic acid—Diarrhoea—Cisplatin—bone cancer	0.000249	0.00125	CcSEcCtD
Ursodeoxycholic acid—Alopecia—Methotrexate—bone cancer	0.000248	0.00125	CcSEcCtD
Ursodeoxycholic acid—Eye disorder—Epirubicin—bone cancer	0.000245	0.00123	CcSEcCtD
Ursodeoxycholic acid—Tinnitus—Epirubicin—bone cancer	0.000245	0.00123	CcSEcCtD
Ursodeoxycholic acid—Malnutrition—Methotrexate—bone cancer	0.000244	0.00123	CcSEcCtD
Ursodeoxycholic acid—Haemoglobin—Doxorubicin—bone cancer	0.000244	0.00123	CcSEcCtD
Ursodeoxycholic acid—Cardiac disorder—Epirubicin—bone cancer	0.000244	0.00122	CcSEcCtD
Ursodeoxycholic acid—Rhinitis—Doxorubicin—bone cancer	0.000244	0.00122	CcSEcCtD
Ursodeoxycholic acid—Haemorrhage—Doxorubicin—bone cancer	0.000243	0.00122	CcSEcCtD
Ursodeoxycholic acid—Pharyngitis—Doxorubicin—bone cancer	0.000241	0.00121	CcSEcCtD
Ursodeoxycholic acid—Urinary tract disorder—Doxorubicin—bone cancer	0.00024	0.0012	CcSEcCtD
Ursodeoxycholic acid—Oedema peripheral—Doxorubicin—bone cancer	0.000239	0.0012	CcSEcCtD
Ursodeoxycholic acid—Connective tissue disorder—Doxorubicin—bone cancer	0.000239	0.0012	CcSEcCtD
Ursodeoxycholic acid—Angiopathy—Epirubicin—bone cancer	0.000238	0.0012	CcSEcCtD
Ursodeoxycholic acid—Urethral disorder—Doxorubicin—bone cancer	0.000238	0.0012	CcSEcCtD
Ursodeoxycholic acid—AKR1C2—Metabolism—ENO2—bone cancer	0.000238	0.00171	CbGpPWpGaD
Ursodeoxycholic acid—Immune system disorder—Epirubicin—bone cancer	0.000237	0.00119	CcSEcCtD
Ursodeoxycholic acid—SLCO1A2—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000237	0.0017	CbGpPWpGaD
Ursodeoxycholic acid—Mediastinal disorder—Epirubicin—bone cancer	0.000237	0.00119	CcSEcCtD
Ursodeoxycholic acid—Back pain—Methotrexate—bone cancer	0.000236	0.00119	CcSEcCtD
Ursodeoxycholic acid—Chills—Epirubicin—bone cancer	0.000236	0.00118	CcSEcCtD
Ursodeoxycholic acid—Arrhythmia—Epirubicin—bone cancer	0.000235	0.00118	CcSEcCtD
Ursodeoxycholic acid—Visual impairment—Doxorubicin—bone cancer	0.000234	0.00118	CcSEcCtD
Ursodeoxycholic acid—CYP2E1—Tryptophan metabolism—MDM2—bone cancer	0.000232	0.00166	CbGpPWpGaD
Ursodeoxycholic acid—Alopecia—Epirubicin—bone cancer	0.000232	0.00117	CcSEcCtD
Ursodeoxycholic acid—Vomiting—Cisplatin—bone cancer	0.000231	0.00116	CcSEcCtD
Ursodeoxycholic acid—Rash—Cisplatin—bone cancer	0.000229	0.00115	CcSEcCtD
Ursodeoxycholic acid—Dermatitis—Cisplatin—bone cancer	0.000229	0.00115	CcSEcCtD
Ursodeoxycholic acid—Malnutrition—Epirubicin—bone cancer	0.000229	0.00115	CcSEcCtD
Ursodeoxycholic acid—Eye disorder—Doxorubicin—bone cancer	0.000227	0.00114	CcSEcCtD
Ursodeoxycholic acid—Ill-defined disorder—Methotrexate—bone cancer	0.000227	0.00114	CcSEcCtD
Ursodeoxycholic acid—Tinnitus—Doxorubicin—bone cancer	0.000227	0.00114	CcSEcCtD
Ursodeoxycholic acid—Anaemia—Methotrexate—bone cancer	0.000226	0.00113	CcSEcCtD
Ursodeoxycholic acid—Cardiac disorder—Doxorubicin—bone cancer	0.000226	0.00113	CcSEcCtD
Ursodeoxycholic acid—Flatulence—Epirubicin—bone cancer	0.000225	0.00113	CcSEcCtD
Ursodeoxycholic acid—Tension—Epirubicin—bone cancer	0.000224	0.00113	CcSEcCtD
Ursodeoxycholic acid—ABCB11—Metabolism—NDUFA12—bone cancer	0.000222	0.00159	CbGpPWpGaD
Ursodeoxycholic acid—Nervousness—Epirubicin—bone cancer	0.000222	0.00111	CcSEcCtD
Ursodeoxycholic acid—Back pain—Epirubicin—bone cancer	0.000221	0.00111	CcSEcCtD
Ursodeoxycholic acid—ABCC4—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000221	0.00158	CbGpPWpGaD
Ursodeoxycholic acid—AKR1C2—Metabolism—DHFR—bone cancer	0.000221	0.00158	CbGpPWpGaD
Ursodeoxycholic acid—Angiopathy—Doxorubicin—bone cancer	0.00022	0.00111	CcSEcCtD
Ursodeoxycholic acid—Malaise—Methotrexate—bone cancer	0.00022	0.00111	CcSEcCtD
Ursodeoxycholic acid—Muscle spasms—Epirubicin—bone cancer	0.00022	0.0011	CcSEcCtD
Ursodeoxycholic acid—Immune system disorder—Doxorubicin—bone cancer	0.000219	0.0011	CcSEcCtD
Ursodeoxycholic acid—Vertigo—Methotrexate—bone cancer	0.000219	0.0011	CcSEcCtD
Ursodeoxycholic acid—Mediastinal disorder—Doxorubicin—bone cancer	0.000219	0.0011	CcSEcCtD
Ursodeoxycholic acid—Leukopenia—Methotrexate—bone cancer	0.000219	0.0011	CcSEcCtD
Ursodeoxycholic acid—Chills—Doxorubicin—bone cancer	0.000218	0.00109	CcSEcCtD
Ursodeoxycholic acid—Arrhythmia—Doxorubicin—bone cancer	0.000217	0.00109	CcSEcCtD
Ursodeoxycholic acid—ABCC2—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000216	0.00155	CbGpPWpGaD
Ursodeoxycholic acid—Nausea—Cisplatin—bone cancer	0.000216	0.00108	CcSEcCtD
Ursodeoxycholic acid—Alopecia—Doxorubicin—bone cancer	0.000215	0.00108	CcSEcCtD
Ursodeoxycholic acid—NR1H4—Gene Expression—NR1I2—bone cancer	0.000215	0.00154	CbGpPWpGaD
Ursodeoxycholic acid—Cough—Methotrexate—bone cancer	0.000213	0.00107	CcSEcCtD
Ursodeoxycholic acid—SLC10A2—Metabolism—ENO2—bone cancer	0.000212	0.00152	CbGpPWpGaD
Ursodeoxycholic acid—Ill-defined disorder—Epirubicin—bone cancer	0.000212	0.00107	CcSEcCtD
Ursodeoxycholic acid—Convulsion—Methotrexate—bone cancer	0.000212	0.00106	CcSEcCtD
Ursodeoxycholic acid—Malnutrition—Doxorubicin—bone cancer	0.000212	0.00106	CcSEcCtD
Ursodeoxycholic acid—Anaemia—Epirubicin—bone cancer	0.000211	0.00106	CcSEcCtD
Ursodeoxycholic acid—Flatulence—Doxorubicin—bone cancer	0.000208	0.00105	CcSEcCtD
Ursodeoxycholic acid—Chest pain—Methotrexate—bone cancer	0.000208	0.00104	CcSEcCtD
Ursodeoxycholic acid—Myalgia—Methotrexate—bone cancer	0.000208	0.00104	CcSEcCtD
Ursodeoxycholic acid—Arthralgia—Methotrexate—bone cancer	0.000208	0.00104	CcSEcCtD
Ursodeoxycholic acid—Tension—Doxorubicin—bone cancer	0.000208	0.00104	CcSEcCtD
Ursodeoxycholic acid—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000207	0.00104	CcSEcCtD
Ursodeoxycholic acid—AKR1C2—Metabolism—GNA11—bone cancer	0.000206	0.00148	CbGpPWpGaD
Ursodeoxycholic acid—Malaise—Epirubicin—bone cancer	0.000206	0.00104	CcSEcCtD
Ursodeoxycholic acid—Discomfort—Methotrexate—bone cancer	0.000205	0.00103	CcSEcCtD
Ursodeoxycholic acid—Nervousness—Doxorubicin—bone cancer	0.000205	0.00103	CcSEcCtD
Ursodeoxycholic acid—Vertigo—Epirubicin—bone cancer	0.000205	0.00103	CcSEcCtD
Ursodeoxycholic acid—Syncope—Epirubicin—bone cancer	0.000205	0.00103	CcSEcCtD
Ursodeoxycholic acid—SLCO1A2—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000205	0.00147	CbGpPWpGaD
Ursodeoxycholic acid—Leukopenia—Epirubicin—bone cancer	0.000205	0.00103	CcSEcCtD
Ursodeoxycholic acid—Back pain—Doxorubicin—bone cancer	0.000205	0.00103	CcSEcCtD
Ursodeoxycholic acid—Muscle spasms—Doxorubicin—bone cancer	0.000203	0.00102	CcSEcCtD
Ursodeoxycholic acid—Palpitations—Epirubicin—bone cancer	0.000202	0.00101	CcSEcCtD
Ursodeoxycholic acid—Confusional state—Methotrexate—bone cancer	0.000201	0.00101	CcSEcCtD
Ursodeoxycholic acid—Loss of consciousness—Epirubicin—bone cancer	0.000201	0.00101	CcSEcCtD
Ursodeoxycholic acid—Cough—Epirubicin—bone cancer	0.000199	0.001	CcSEcCtD
Ursodeoxycholic acid—Convulsion—Epirubicin—bone cancer	0.000198	0.000995	CcSEcCtD
Ursodeoxycholic acid—Infection—Methotrexate—bone cancer	0.000198	0.000995	CcSEcCtD
Ursodeoxycholic acid—Hypertension—Epirubicin—bone cancer	0.000197	0.000991	CcSEcCtD
Ursodeoxycholic acid—SLC10A2—Metabolism—DHFR—bone cancer	0.000197	0.00141	CbGpPWpGaD
Ursodeoxycholic acid—Ill-defined disorder—Doxorubicin—bone cancer	0.000196	0.000985	CcSEcCtD
Ursodeoxycholic acid—Nervous system disorder—Methotrexate—bone cancer	0.000196	0.000982	CcSEcCtD
Ursodeoxycholic acid—Anaemia—Doxorubicin—bone cancer	0.000195	0.000982	CcSEcCtD
Ursodeoxycholic acid—Thrombocytopenia—Methotrexate—bone cancer	0.000195	0.00098	CcSEcCtD
Ursodeoxycholic acid—Chest pain—Epirubicin—bone cancer	0.000195	0.000977	CcSEcCtD
Ursodeoxycholic acid—Arthralgia—Epirubicin—bone cancer	0.000195	0.000977	CcSEcCtD
Ursodeoxycholic acid—Myalgia—Epirubicin—bone cancer	0.000195	0.000977	CcSEcCtD
Ursodeoxycholic acid—Skin disorder—Methotrexate—bone cancer	0.000194	0.000972	CcSEcCtD
Ursodeoxycholic acid—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000193	0.000971	CcSEcCtD
Ursodeoxycholic acid—Hyperhidrosis—Methotrexate—bone cancer	0.000193	0.000968	CcSEcCtD
Ursodeoxycholic acid—Discomfort—Epirubicin—bone cancer	0.000192	0.000966	CcSEcCtD
Ursodeoxycholic acid—Malaise—Doxorubicin—bone cancer	0.000191	0.000958	CcSEcCtD
Ursodeoxycholic acid—Dry mouth—Epirubicin—bone cancer	0.00019	0.000956	CcSEcCtD
Ursodeoxycholic acid—Vertigo—Doxorubicin—bone cancer	0.00019	0.000954	CcSEcCtD
Ursodeoxycholic acid—Anorexia—Methotrexate—bone cancer	0.00019	0.000954	CcSEcCtD
Ursodeoxycholic acid—Syncope—Doxorubicin—bone cancer	0.00019	0.000952	CcSEcCtD
Ursodeoxycholic acid—Leukopenia—Doxorubicin—bone cancer	0.000189	0.000951	CcSEcCtD
Ursodeoxycholic acid—Confusional state—Epirubicin—bone cancer	0.000188	0.000945	CcSEcCtD
Ursodeoxycholic acid—AKR1C2—Metabolism—CYP3A4—bone cancer	0.000187	0.00134	CbGpPWpGaD
Ursodeoxycholic acid—Palpitations—Doxorubicin—bone cancer	0.000187	0.000939	CcSEcCtD
Ursodeoxycholic acid—Oedema—Epirubicin—bone cancer	0.000187	0.000937	CcSEcCtD
Ursodeoxycholic acid—ABCC2—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000186	0.00133	CbGpPWpGaD
Ursodeoxycholic acid—Hypotension—Methotrexate—bone cancer	0.000186	0.000935	CcSEcCtD
Ursodeoxycholic acid—AKR1C2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	0.000186	0.00133	CbGpPWpGaD
Ursodeoxycholic acid—Loss of consciousness—Doxorubicin—bone cancer	0.000186	0.000933	CcSEcCtD
Ursodeoxycholic acid—SLCO1A2—Metabolism—NDUFA12—bone cancer	0.000185	0.00133	CbGpPWpGaD
Ursodeoxycholic acid—Infection—Epirubicin—bone cancer	0.000185	0.000931	CcSEcCtD
Ursodeoxycholic acid—Cough—Doxorubicin—bone cancer	0.000185	0.000927	CcSEcCtD
Ursodeoxycholic acid—ABCB11—Metabolism—NT5C3A—bone cancer	0.000184	0.00132	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A2—Metabolism—GNA11—bone cancer	0.000184	0.00132	CbGpPWpGaD
Ursodeoxycholic acid—Shock—Epirubicin—bone cancer	0.000184	0.000922	CcSEcCtD
Ursodeoxycholic acid—Convulsion—Doxorubicin—bone cancer	0.000183	0.00092	CcSEcCtD
Ursodeoxycholic acid—Nervous system disorder—Epirubicin—bone cancer	0.000183	0.000919	CcSEcCtD
Ursodeoxycholic acid—Thrombocytopenia—Epirubicin—bone cancer	0.000183	0.000917	CcSEcCtD
Ursodeoxycholic acid—Hypertension—Doxorubicin—bone cancer	0.000183	0.000917	CcSEcCtD
Ursodeoxycholic acid—Tachycardia—Epirubicin—bone cancer	0.000182	0.000914	CcSEcCtD
Ursodeoxycholic acid—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000182	0.000912	CcSEcCtD
Ursodeoxycholic acid—Skin disorder—Epirubicin—bone cancer	0.000181	0.00091	CcSEcCtD
Ursodeoxycholic acid—Hyperhidrosis—Epirubicin—bone cancer	0.00018	0.000906	CcSEcCtD
Ursodeoxycholic acid—Insomnia—Methotrexate—bone cancer	0.00018	0.000905	CcSEcCtD
Ursodeoxycholic acid—Myalgia—Doxorubicin—bone cancer	0.00018	0.000904	CcSEcCtD
Ursodeoxycholic acid—Chest pain—Doxorubicin—bone cancer	0.00018	0.000904	CcSEcCtD
Ursodeoxycholic acid—Arthralgia—Doxorubicin—bone cancer	0.00018	0.000904	CcSEcCtD
Ursodeoxycholic acid—Paraesthesia—Methotrexate—bone cancer	0.000179	0.000899	CcSEcCtD
Ursodeoxycholic acid—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000179	0.000898	CcSEcCtD
Ursodeoxycholic acid—Discomfort—Doxorubicin—bone cancer	0.000178	0.000893	CcSEcCtD
Ursodeoxycholic acid—Anorexia—Epirubicin—bone cancer	0.000178	0.000893	CcSEcCtD
Ursodeoxycholic acid—Dyspnoea—Methotrexate—bone cancer	0.000178	0.000892	CcSEcCtD
Ursodeoxycholic acid—Somnolence—Methotrexate—bone cancer	0.000177	0.00089	CcSEcCtD
Ursodeoxycholic acid—Dry mouth—Doxorubicin—bone cancer	0.000176	0.000884	CcSEcCtD
Ursodeoxycholic acid—CYP2E1—Biological oxidations—CYP3A4—bone cancer	0.000176	0.00126	CbGpPWpGaD
Ursodeoxycholic acid—Dyspepsia—Methotrexate—bone cancer	0.000175	0.000881	CcSEcCtD
Ursodeoxycholic acid—Hypotension—Epirubicin—bone cancer	0.000174	0.000875	CcSEcCtD
Ursodeoxycholic acid—Confusional state—Doxorubicin—bone cancer	0.000174	0.000874	CcSEcCtD
Ursodeoxycholic acid—CYP2E1—Metapathway biotransformation—CYP3A4—bone cancer	0.000173	0.00124	CbGpPWpGaD
Ursodeoxycholic acid—Decreased appetite—Methotrexate—bone cancer	0.000173	0.00087	CcSEcCtD
Ursodeoxycholic acid—Oedema—Doxorubicin—bone cancer	0.000173	0.000867	CcSEcCtD
Ursodeoxycholic acid—Gastrointestinal disorder—Methotrexate—bone cancer	0.000172	0.000864	CcSEcCtD
Ursodeoxycholic acid—Fatigue—Methotrexate—bone cancer	0.000172	0.000863	CcSEcCtD
Ursodeoxycholic acid—Infection—Doxorubicin—bone cancer	0.000171	0.000861	CcSEcCtD
Ursodeoxycholic acid—Pain—Methotrexate—bone cancer	0.00017	0.000856	CcSEcCtD
Ursodeoxycholic acid—Musculoskeletal discomfort—Epirubicin—bone cancer	0.00017	0.000854	CcSEcCtD
Ursodeoxycholic acid—ABCC4—Hemostasis—SPARC—bone cancer	0.00017	0.00122	CbGpPWpGaD
Ursodeoxycholic acid—Shock—Doxorubicin—bone cancer	0.00017	0.000853	CcSEcCtD
Ursodeoxycholic acid—Nervous system disorder—Doxorubicin—bone cancer	0.000169	0.00085	CcSEcCtD
Ursodeoxycholic acid—Thrombocytopenia—Doxorubicin—bone cancer	0.000169	0.000849	CcSEcCtD
Ursodeoxycholic acid—Insomnia—Epirubicin—bone cancer	0.000169	0.000847	CcSEcCtD
Ursodeoxycholic acid—Tachycardia—Doxorubicin—bone cancer	0.000168	0.000846	CcSEcCtD
Ursodeoxycholic acid—Skin disorder—Doxorubicin—bone cancer	0.000168	0.000842	CcSEcCtD
Ursodeoxycholic acid—Paraesthesia—Epirubicin—bone cancer	0.000168	0.000841	CcSEcCtD
Ursodeoxycholic acid—Hyperhidrosis—Doxorubicin—bone cancer	0.000167	0.000838	CcSEcCtD
Ursodeoxycholic acid—SLC10A2—Metabolism—CYP3A4—bone cancer	0.000167	0.00119	CbGpPWpGaD
Ursodeoxycholic acid—Dyspnoea—Epirubicin—bone cancer	0.000166	0.000835	CcSEcCtD
Ursodeoxycholic acid—SLC10A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	0.000166	0.00119	CbGpPWpGaD
Ursodeoxycholic acid—Somnolence—Epirubicin—bone cancer	0.000166	0.000833	CcSEcCtD
Ursodeoxycholic acid—Anorexia—Doxorubicin—bone cancer	0.000165	0.000826	CcSEcCtD
Ursodeoxycholic acid—Feeling abnormal—Methotrexate—bone cancer	0.000164	0.000825	CcSEcCtD
Ursodeoxycholic acid—Dyspepsia—Epirubicin—bone cancer	0.000164	0.000825	CcSEcCtD
Ursodeoxycholic acid—Gastrointestinal pain—Methotrexate—bone cancer	0.000163	0.000819	CcSEcCtD
Ursodeoxycholic acid—Decreased appetite—Epirubicin—bone cancer	0.000162	0.000814	CcSEcCtD
Ursodeoxycholic acid—Hypotension—Doxorubicin—bone cancer	0.000161	0.00081	CcSEcCtD
Ursodeoxycholic acid—Gastrointestinal disorder—Epirubicin—bone cancer	0.000161	0.000809	CcSEcCtD
Ursodeoxycholic acid—Fatigue—Epirubicin—bone cancer	0.000161	0.000808	CcSEcCtD
Ursodeoxycholic acid—AKR1C2—Metabolism—GSTP1—bone cancer	0.00016	0.00115	CbGpPWpGaD
Ursodeoxycholic acid—Constipation—Epirubicin—bone cancer	0.00016	0.000801	CcSEcCtD
Ursodeoxycholic acid—Pain—Epirubicin—bone cancer	0.00016	0.000801	CcSEcCtD
Ursodeoxycholic acid—NR1H4—Gene Expression—EIF2S1—bone cancer	0.000158	0.00113	CbGpPWpGaD
Ursodeoxycholic acid—Urticaria—Methotrexate—bone cancer	0.000158	0.000795	CcSEcCtD
Ursodeoxycholic acid—Abdominal pain—Methotrexate—bone cancer	0.000158	0.000791	CcSEcCtD
Ursodeoxycholic acid—Body temperature increased—Methotrexate—bone cancer	0.000158	0.000791	CcSEcCtD
Ursodeoxycholic acid—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000157	0.00079	CcSEcCtD
Ursodeoxycholic acid—Insomnia—Doxorubicin—bone cancer	0.000156	0.000784	CcSEcCtD
Ursodeoxycholic acid—ABCC4—Hemostasis—GNA11—bone cancer	0.000155	0.00111	CbGpPWpGaD
Ursodeoxycholic acid—Paraesthesia—Doxorubicin—bone cancer	0.000155	0.000778	CcSEcCtD
Ursodeoxycholic acid—Dyspnoea—Doxorubicin—bone cancer	0.000154	0.000773	CcSEcCtD
Ursodeoxycholic acid—Feeling abnormal—Epirubicin—bone cancer	0.000154	0.000772	CcSEcCtD
Ursodeoxycholic acid—SLCO1A2—Metabolism—NT5C3A—bone cancer	0.000154	0.0011	CbGpPWpGaD
Ursodeoxycholic acid—Somnolence—Doxorubicin—bone cancer	0.000153	0.000771	CcSEcCtD
Ursodeoxycholic acid—Gastrointestinal pain—Epirubicin—bone cancer	0.000153	0.000766	CcSEcCtD
Ursodeoxycholic acid—Dyspepsia—Doxorubicin—bone cancer	0.000152	0.000763	CcSEcCtD
Ursodeoxycholic acid—CYP2E1—Biological oxidations—GSTP1—bone cancer	0.00015	0.00108	CbGpPWpGaD
Ursodeoxycholic acid—Decreased appetite—Doxorubicin—bone cancer	0.00015	0.000754	CcSEcCtD
Ursodeoxycholic acid—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000149	0.000748	CcSEcCtD
Ursodeoxycholic acid—Fatigue—Doxorubicin—bone cancer	0.000149	0.000747	CcSEcCtD
Ursodeoxycholic acid—CYP2E1—Metapathway biotransformation—GSTP1—bone cancer	0.000148	0.00106	CbGpPWpGaD
Ursodeoxycholic acid—Urticaria—Epirubicin—bone cancer	0.000148	0.000744	CcSEcCtD
Ursodeoxycholic acid—Pain—Doxorubicin—bone cancer	0.000148	0.000741	CcSEcCtD
Ursodeoxycholic acid—Constipation—Doxorubicin—bone cancer	0.000148	0.000741	CcSEcCtD
Ursodeoxycholic acid—Abdominal pain—Epirubicin—bone cancer	0.000147	0.000741	CcSEcCtD
Ursodeoxycholic acid—Body temperature increased—Epirubicin—bone cancer	0.000147	0.000741	CcSEcCtD
Ursodeoxycholic acid—Hypersensitivity—Methotrexate—bone cancer	0.000147	0.000738	CcSEcCtD
Ursodeoxycholic acid—Asthenia—Methotrexate—bone cancer	0.000143	0.000718	CcSEcCtD
Ursodeoxycholic acid—SLC10A2—Metabolism—GSTP1—bone cancer	0.000143	0.00102	CbGpPWpGaD
Ursodeoxycholic acid—Feeling abnormal—Doxorubicin—bone cancer	0.000142	0.000714	CcSEcCtD
Ursodeoxycholic acid—Gastrointestinal pain—Doxorubicin—bone cancer	0.000141	0.000709	CcSEcCtD
Ursodeoxycholic acid—Pruritus—Methotrexate—bone cancer	0.000141	0.000708	CcSEcCtD
Ursodeoxycholic acid—ABCC4—Hemostasis—IL3—bone cancer	0.000141	0.00101	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Gene Expression—EZH2—bone cancer	0.000138	0.000986	CbGpPWpGaD
Ursodeoxycholic acid—Hypersensitivity—Epirubicin—bone cancer	0.000137	0.00069	CcSEcCtD
Ursodeoxycholic acid—Urticaria—Doxorubicin—bone cancer	0.000137	0.000689	CcSEcCtD
Ursodeoxycholic acid—SLC10A1—Metabolism—ENO2—bone cancer	0.000137	0.00098	CbGpPWpGaD
Ursodeoxycholic acid—Abdominal pain—Doxorubicin—bone cancer	0.000136	0.000685	CcSEcCtD
Ursodeoxycholic acid—Body temperature increased—Doxorubicin—bone cancer	0.000136	0.000685	CcSEcCtD
Ursodeoxycholic acid—Diarrhoea—Methotrexate—bone cancer	0.000136	0.000685	CcSEcCtD
Ursodeoxycholic acid—Asthenia—Epirubicin—bone cancer	0.000134	0.000672	CcSEcCtD
Ursodeoxycholic acid—Pruritus—Epirubicin—bone cancer	0.000132	0.000663	CcSEcCtD
Ursodeoxycholic acid—Dizziness—Methotrexate—bone cancer	0.000132	0.000662	CcSEcCtD
Ursodeoxycholic acid—Diarrhoea—Epirubicin—bone cancer	0.000128	0.000641	CcSEcCtD
Ursodeoxycholic acid—Hypersensitivity—Doxorubicin—bone cancer	0.000127	0.000639	CcSEcCtD
Ursodeoxycholic acid—SLC10A1—Metabolism—DHFR—bone cancer	0.000127	0.000909	CbGpPWpGaD
Ursodeoxycholic acid—Vomiting—Methotrexate—bone cancer	0.000127	0.000636	CcSEcCtD
Ursodeoxycholic acid—Rash—Methotrexate—bone cancer	0.000126	0.000631	CcSEcCtD
Ursodeoxycholic acid—Dermatitis—Methotrexate—bone cancer	0.000126	0.000631	CcSEcCtD
Ursodeoxycholic acid—Headache—Methotrexate—bone cancer	0.000125	0.000627	CcSEcCtD
Ursodeoxycholic acid—NR1H4—Metabolism—ENO2—bone cancer	0.000124	0.000888	CbGpPWpGaD
Ursodeoxycholic acid—Asthenia—Doxorubicin—bone cancer	0.000124	0.000622	CcSEcCtD
Ursodeoxycholic acid—Dizziness—Epirubicin—bone cancer	0.000123	0.000619	CcSEcCtD
Ursodeoxycholic acid—Pruritus—Doxorubicin—bone cancer	0.000122	0.000613	CcSEcCtD
Ursodeoxycholic acid—Vomiting—Epirubicin—bone cancer	0.000119	0.000596	CcSEcCtD
Ursodeoxycholic acid—SLC10A1—Metabolism—GNA11—bone cancer	0.000119	0.000849	CbGpPWpGaD
Ursodeoxycholic acid—Nausea—Methotrexate—bone cancer	0.000118	0.000595	CcSEcCtD
Ursodeoxycholic acid—Diarrhoea—Doxorubicin—bone cancer	0.000118	0.000593	CcSEcCtD
Ursodeoxycholic acid—Rash—Epirubicin—bone cancer	0.000118	0.000591	CcSEcCtD
Ursodeoxycholic acid—Dermatitis—Epirubicin—bone cancer	0.000118	0.00059	CcSEcCtD
Ursodeoxycholic acid—Headache—Epirubicin—bone cancer	0.000117	0.000587	CcSEcCtD
Ursodeoxycholic acid—NR1H4—Metabolism—DHFR—bone cancer	0.000115	0.000824	CbGpPWpGaD
Ursodeoxycholic acid—Dizziness—Doxorubicin—bone cancer	0.000114	0.000573	CcSEcCtD
Ursodeoxycholic acid—Nausea—Epirubicin—bone cancer	0.000111	0.000556	CcSEcCtD
Ursodeoxycholic acid—Vomiting—Doxorubicin—bone cancer	0.00011	0.000551	CcSEcCtD
Ursodeoxycholic acid—Rash—Doxorubicin—bone cancer	0.000109	0.000547	CcSEcCtD
Ursodeoxycholic acid—Dermatitis—Doxorubicin—bone cancer	0.000109	0.000546	CcSEcCtD
Ursodeoxycholic acid—Headache—Doxorubicin—bone cancer	0.000108	0.000543	CcSEcCtD
Ursodeoxycholic acid—SLC10A1—Metabolism—CYP3A4—bone cancer	0.000108	0.00077	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Metabolism—GNA11—bone cancer	0.000108	0.00077	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	0.000107	0.000766	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Metabolism—NDUFA12—bone cancer	0.000105	0.000755	CbGpPWpGaD
Ursodeoxycholic acid—Nausea—Doxorubicin—bone cancer	0.000103	0.000515	CcSEcCtD
Ursodeoxycholic acid—NR1H4—Metabolism—CYP3A4—bone cancer	9.75e-05	0.000698	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	9.7e-05	0.000695	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—Hemostasis—PLAU—bone cancer	9.24e-05	0.000662	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A1—Metabolism—GSTP1—bone cancer	9.2e-05	0.000659	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Metabolism—NT5C3A—bone cancer	8.73e-05	0.000626	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Metabolism—GSTP1—bone cancer	8.34e-05	0.000597	CbGpPWpGaD
Ursodeoxycholic acid—AKR1C2—Metabolism—PTGS2—bone cancer	8.29e-05	0.000594	CbGpPWpGaD
Ursodeoxycholic acid—ABCB11—Metabolism—ENO2—bone cancer	8.06e-05	0.000577	CbGpPWpGaD
Ursodeoxycholic acid—ABCB11—Metabolism—DHFR—bone cancer	7.48e-05	0.000536	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A2—Metabolism—PTGS2—bone cancer	7.39e-05	0.000529	CbGpPWpGaD
Ursodeoxycholic acid—ABCB11—Metabolism—GNA11—bone cancer	6.99e-05	0.000501	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—Metabolism—ENO2—bone cancer	6.73e-05	0.000482	CbGpPWpGaD
Ursodeoxycholic acid—ABCB11—Metabolism—CYP3A4—bone cancer	6.34e-05	0.000454	CbGpPWpGaD
Ursodeoxycholic acid—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	6.3e-05	0.000451	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—Metabolism—DHFR—bone cancer	6.24e-05	0.000447	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—Metabolism—GNA11—bone cancer	5.84e-05	0.000418	CbGpPWpGaD
Ursodeoxycholic acid—ABCB11—Metabolism—GSTP1—bone cancer	5.42e-05	0.000388	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—Metabolism—CYP3A4—bone cancer	5.29e-05	0.000379	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	5.26e-05	0.000377	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A1—Metabolism—PTGS2—bone cancer	4.76e-05	0.000341	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—Metabolism—GSTP1—bone cancer	4.52e-05	0.000324	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Metabolism—PTGS2—bone cancer	4.32e-05	0.000309	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Metabolism—ENO2—bone cancer	3.83e-05	0.000274	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—Hemostasis—TP53—bone cancer	3.72e-05	0.000266	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Metabolism—DHFR—bone cancer	3.55e-05	0.000254	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Metabolism—GNA11—bone cancer	3.32e-05	0.000238	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Metabolism—CYP3A4—bone cancer	3.01e-05	0.000215	CbGpPWpGaD
Ursodeoxycholic acid—ABCB11—Metabolism—PTGS2—bone cancer	2.81e-05	0.000201	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Metabolism—GSTP1—bone cancer	2.57e-05	0.000184	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—Metabolism—PTGS2—bone cancer	2.34e-05	0.000168	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Metabolism—PTGS2—bone cancer	1.33e-05	9.54e-05	CbGpPWpGaD
